Skip to content

A study for evaluating the effect of food containing lactic acid bacteria on relating nasal and ocular symptoms.

A study for evaluating the effect of food containing lactic acid bacteria on relating nasal and ocular symptoms. - A study for evaluating the effect of food containing lactic acid bacteria on relating nasal and ocular symptoms.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000037571
Enrollment
50
Registered
2020-11-15
Start date
2019-08-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Ingestion of food containing lactic acid bacteria for 8 consecutive weeks Ingestion of placebo without lactic acid bacteria for 8 consecutive weeks

Sponsors

TTC Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Males and females from 20 to 64 years of age. (2)Subjects who complained of eye and nasal discomfort and judged tested positive for Japanese cedar pollen specific IgE. (3)Subjects who are judged as suitable for the study by the investigator. (4)Subjects who obtained the consent about participation in the study. (5)Subjects who do not take antiallergic drug account for more than half of whole.

Exclusion criteria

Exclusion criteria: (1)Subjects who routinely take food or medicine containing lactic acid bacteria or natto bacteria. (2)Subjects who have severe nasal and eye symptoms affecting judgement of discomfort. (3)Subjects who routinely take medicines affecting the test result. (4)Subjects who are under medication (specific desensitization therapy) which may influence the outcome of the study. (5)Subjects who are engaged in drive a car or operate a hazardous machine. (6)Subjects judged as unsuitable for the stuzy by the investigator for laboratory evidence or cardiopulmonary function. (7)Subjects who have a disease requiring regular medication or a history of serious disease for which medication was required. (8)Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination. (9)Subjects who are liable to cause an allergy related to the study. (10)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire. (11)Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study. (12)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. (13)Subjects who are judged as unsuitable for the study by the investigator for other reason.

Design outcomes

Primary

MeasureTime frame
Subject's nasal or ocular symptom in an environmental exposure unit(EEU). (the number of sneezes and nose blowing, eye itching, watery eyes)

Secondary

MeasureTime frame
1.Visual analog scale(EEU) (nasal blockage, nasal itching, throat symptoms, sleepiness, disturbance of daily living) 2.Visual analog scale(after exposure Japanese cedar pollen) (the number of sneezes and nose blowing, nasal blockage, nasal itching, eye itching, watery eyes, throat symptoms, sleepiness, disturbance of daily living) 3.QOL questionnaire, diagnosis subject's noses, eosinophil of nasal mucus and skin questionnaire.

Countries

Japan

Contacts

Public ContactChiharu Goto

TTC Co., Ltd. Clinical Research Planning Department

c.goto@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026